Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis

Mary Beth Dorr, Anita L. Nelson, Philip R. Mayer, Radhika P. Ranganath, Paul M. Norris, Eileen C. Helzner, Richard A Preston

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

In this open-label, randomized, multiple-dose, two-treatment crossover study, 24 postmenopausal women with moderate to severe atrophic vaginitis received 0.3 mg conjugated estrogens daily for 14 days: 7 days orally (0.3 mg tablet) and 7 days vaginally (0.5 g cream). Steady-state plasma concentrations of E2 and estrone were one-third lower after vaginal versus oral administration of conjugated estrogens.

Original languageEnglish
Pages (from-to)2365-2368
Number of pages4
JournalFertility and Sterility
Volume94
Issue number6
DOIs
StatePublished - Nov 1 2010

Fingerprint

Atrophic Vaginitis
Intravaginal Administration
Conjugated (USP) Estrogens
Estrogens
Estrone
Cross-Over Studies
Tablets
Oral Administration
Therapeutics

Keywords

  • absorption
  • Conjugated estrogens
  • ET
  • pharmacokinetics
  • vaginal cream

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis. / Dorr, Mary Beth; Nelson, Anita L.; Mayer, Philip R.; Ranganath, Radhika P.; Norris, Paul M.; Helzner, Eileen C.; Preston, Richard A.

In: Fertility and Sterility, Vol. 94, No. 6, 01.11.2010, p. 2365-2368.

Research output: Contribution to journalArticle

Dorr, Mary Beth ; Nelson, Anita L. ; Mayer, Philip R. ; Ranganath, Radhika P. ; Norris, Paul M. ; Helzner, Eileen C. ; Preston, Richard A. / Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis. In: Fertility and Sterility. 2010 ; Vol. 94, No. 6. pp. 2365-2368.
@article{98145775448e464089b4dec8b6da8213,
title = "Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis",
abstract = "In this open-label, randomized, multiple-dose, two-treatment crossover study, 24 postmenopausal women with moderate to severe atrophic vaginitis received 0.3 mg conjugated estrogens daily for 14 days: 7 days orally (0.3 mg tablet) and 7 days vaginally (0.5 g cream). Steady-state plasma concentrations of E2 and estrone were one-third lower after vaginal versus oral administration of conjugated estrogens.",
keywords = "absorption, Conjugated estrogens, ET, pharmacokinetics, vaginal cream",
author = "Dorr, {Mary Beth} and Nelson, {Anita L.} and Mayer, {Philip R.} and Ranganath, {Radhika P.} and Norris, {Paul M.} and Helzner, {Eileen C.} and Preston, {Richard A}",
year = "2010",
month = "11",
day = "1",
doi = "10.1016/j.fertnstert.2010.03.076",
language = "English",
volume = "94",
pages = "2365--2368",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis

AU - Dorr, Mary Beth

AU - Nelson, Anita L.

AU - Mayer, Philip R.

AU - Ranganath, Radhika P.

AU - Norris, Paul M.

AU - Helzner, Eileen C.

AU - Preston, Richard A

PY - 2010/11/1

Y1 - 2010/11/1

N2 - In this open-label, randomized, multiple-dose, two-treatment crossover study, 24 postmenopausal women with moderate to severe atrophic vaginitis received 0.3 mg conjugated estrogens daily for 14 days: 7 days orally (0.3 mg tablet) and 7 days vaginally (0.5 g cream). Steady-state plasma concentrations of E2 and estrone were one-third lower after vaginal versus oral administration of conjugated estrogens.

AB - In this open-label, randomized, multiple-dose, two-treatment crossover study, 24 postmenopausal women with moderate to severe atrophic vaginitis received 0.3 mg conjugated estrogens daily for 14 days: 7 days orally (0.3 mg tablet) and 7 days vaginally (0.5 g cream). Steady-state plasma concentrations of E2 and estrone were one-third lower after vaginal versus oral administration of conjugated estrogens.

KW - absorption

KW - Conjugated estrogens

KW - ET

KW - pharmacokinetics

KW - vaginal cream

UR - http://www.scopus.com/inward/record.url?scp=78049263857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049263857&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2010.03.076

DO - 10.1016/j.fertnstert.2010.03.076

M3 - Article

C2 - 20466363

AN - SCOPUS:78049263857

VL - 94

SP - 2365

EP - 2368

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 6

ER -